Drug delivery technology has a wide spectrum, which is continuously being upgraded at a
stupendous speed. Different fabricated nanoparticles and drugs possessing low solubility …

Background Glioblastoma, or glioblastoma multiforme (GBM), remains a fatal cancer type
despite the remarkable progress in understanding the genesis and propagation of the tumor …

Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) have opened new
horizons in the pharmaceutical industry since they play a fundamental role in the field of …

The central nervous system (CNS), namely the brain, still remains as the hardest area of the
human body to achieve adequate concentration levels of most drugs, mainly due to the …

Glioblastoma multiforme, a grade IV glioma, is the most frequently occurring and invasive
primary tumor of the central nervous system, which causes about 4% of cancer-associated …

Lipidic nanoparticles have recently gained attention in cancer research. In this review we
are focused on the solid lipid nanoparticle (SLN) and nanostructured lipid carrier (NLC) …

Solid Lipid Nanoparticles (SLNs) have attracted increasing scientific and commercial
attention as colloidal drug carriers during the last decade. They have emerged as a potential …

Lipid-based nanoparticles for drug delivery have been employed in the development of
nanomedicine for various applications. One such versatile nanoparticle type is …

Significant efforts have been made in research to discover newer neurotherapeutics,
however, the rate of reported neurological disorders has been increasing at an alarming …

Most cancer disease can be treated by the parenteral anticancer delivery method. The
intravenous route takes the wholly bioavailable, accurate dose of the drug immediately to …